The Bald Truth: Why Wall Street's Next Goldmine May Be a Scapegoat for Deeper Issues The recent surge in stocks of companies developing baldness treatments has sent shockwaves through the investment community, with analysts predicting a multibillion dollar market potential.
Pattern hair loss affects an estimated 50 million men and 30 million women in the US – a staggering number that has been largely underserved by pharmaceuticals.
However, this narrative is more complex than it initially seems.